2Vivekanandan S, Nayak SD. Valproate - induced hyperammone- mic encephalopathy enhanced by topiramate and phenobarbitone: a case report and an update [ J ]. Ann Indian Acad Neurol, 2010, 13(2) : 145 -147.
3Ziyeh S, Thiel T, Spreer J, et al. Valproate- induced encepha- lopathy: assessment with MR imaging and 1H MR spectroscopy [J]. Epilepsia, 2002, 43(9): 1101 -1105.
4Gurjar M, Sinjhal S, Baronia AK, et al. Valproate - induced hy- perammonemic encephalopathy; A reminder of rare complication of valproate[ J]. J Emerg Trauma Shock, 2011 , 4(2) : 321 -322.
5Carr RB Shrewsbuny K. Hyperammonemia due to valproic acid in the psychiatric setting [ J]. Am J Psychiatry, 2007, 164 ( 7 ) : 1020 - 1027.
2Agarwal R, Sharma S, Chhillar N, et al. Hyperammonemia andhepatic status during valproate therapy[J]. Indian Journal ofClinical Biochemistry,2009,24(4):366-369.
3Topczewski A, Caboclo LOSF. Valproate-induced acuteencephalopathy[J]. Einstein,2008,6( 1):86-87.
4Lewis C, Deshpande A, Tesar GE, et al. Valproate-inducedhyperammonemic encephalopathy: a brief reviewfj]. Curr MedRes Opin,2012,28(6):1039-1042.
5Lheureux PE, Hantson P. Carnitine in the treatment of valproicacid-induced toxicity[J]. Clin Toxicol (Phila),2009,47(2):101-111.
6Perucca E. Pharmacological and therapeutic properties ofvalproate: a summary after 35 years of clinical experience[J].CNS Drugs,2002,16(10):695-714.
7Konig SA, Schenk M, Sick C, et al. Fatal liver failure associatedwith valproate therapy in a patient with Friedreich、disease:review of valproate hepatotoxicity in adults[J]. Epilepsia, 1999,40(7):1036-1040.
